Efficacy and tolerability of a new extended-release formulation of nicotinic acid in Korean adults with mixed dyslipidemia: an 8-week, multicenter, prospective, randomized, double-blind, and placebo-controlled trial.

Abstract

BACKGROUND Nicotinic acid is an effective treatment for dyslipidemia. Patients are more tolerant of the extended-release form of nicotinic acid because it has a lower incidence of side effects, such as facial flushing, than the immediate-release formulation. OBJECTIVE This study was designed to evaluate the efficacy and tolerability of an experimental… (More)
DOI: 10.1016/j.clinthera.2011.08.015

Topics

Cite this paper

@article{Kim2011EfficacyAT, title={Efficacy and tolerability of a new extended-release formulation of nicotinic acid in Korean adults with mixed dyslipidemia: an 8-week, multicenter, prospective, randomized, double-blind, and placebo-controlled trial.}, author={Sang-Yong Kim and Minkyung Kim and Hae Young Lee and Hyun-Jae Kang and Y. H. Kim and Byung Joo Park and Hyo Soo Kim}, journal={Clinical therapeutics}, year={2011}, volume={33 10}, pages={1357-64} }